Form 4: Jazz Pharmaceuticals Director Reports Stock Transaction
Insider Transaction (Form 4)
Patrick Kennedy, a Director of Jazz Pharmaceuticals plc, reported multiple transactions in common stock on August 31, 2026.
Summary
- Tax/exercise-price withholding: disposed of 15 Ordinary Shares at $244.06 ($3,661) on August 31, 2026; holds 8,292 after (Direct).
- Tax/exercise-price withholding: disposed of 1,840 Ordinary Shares at $241.39 ($444,158) on August 31, 2026; holds 6,452 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Patrick Kennedy — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-31 | Tax/exercise-price withholding | Ordinary Shares | 15 | $244 | $3.7K | 8,292 |
| 2026-08-31 | Tax/exercise-price withholding | Ordinary Shares | 1,840 | $241 | $444.2K | 6,452 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-31 | Tax/exercise-price withholding (15 shares) |
| 2026-08-31 | Tax/exercise-price withholding (1,840 shares) |
Keywords
insider transaction, Form 4, JAZZ, Jazz Pharmaceuticals plc, neutral, Patrick Kennedy
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.